| Literature DB >> 33588989 |
Katina D Hulme1, Anjana C Karawita1, Cassandra Pegg1, Myrna Jm Bunte1, Helle Bielefeldt-Ohmann1,2,3, Conor J Bloxham4, Silvie Van den Hoecke5,6, Yin Xiang Setoh1,2,7, Bram Vrancken8, Monique Spronken9, Lauren E Steele1, Nathalie Aj Verzele1, Kyle R Upton1, Alexander A Khromykh1,2, Keng Yih Chew1, Maria Sukkar10, Simon Phipps2,11, Kirsty R Short1,2.
Abstract
Influenza virus has a high mutation rate, such that within one host different viral variants can emerge. Evidence suggests that influenza virus variants are more prevalent in pregnant and/or obese individuals due to their impaired interferon response. We have recently shown that the non-allergic, paucigranulocytic subtype of asthma is associated with impaired type I interferon production. Here, we seek to address if this is associated with an increased emergence of influenza virus variants. Compared to controls, mice with paucigranulocytic asthma had increased disease severity and an increased emergence of influenza virus variants. Specifically, PB1 mutations exclusively detected in asthmatic mice were associated with increased polymerase activity. Furthermore, asthmatic host-derived virus led to increased disease severity in wild-type mice. Taken together, these data suggest that at least a subset of patients with asthma may be more susceptible to severe influenza and may be a possible source of new influenza virus variants.Entities:
Keywords: asthma; host-pathogen evolution; human; immunology; infectious disease; inflammation; influenza virus; interferons; microbiology; mouse; mutation
Mesh:
Substances:
Year: 2021 PMID: 33588989 PMCID: PMC7886327 DOI: 10.7554/eLife.61803
Source DB: PubMed Journal: Elife ISSN: 2050-084X Impact factor: 8.140